Jillian C Bensko
Overview
Explore the profile of Jillian C Bensko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mullur J, Maurer R, Ryan T, McGill A, Bensko J, Laidlaw T, et al.
Am J Rhinol Allergy
. 2024 Nov;
39(2):90-97.
PMID: 39574218
Background: Patients with aspirin-exacerbated respiratory disease (AERD) have difficult-to-treat asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and often require treatment with biologic therapy for asthma or CRSwNP. Healthcare utilization...
2.
Corcoran R, Bailey L, Brown A, Buchheit K, Bensko J, Laidlaw T
J Allergy Clin Immunol Pract
. 2024 Mar;
12(7):1907-1909.e1.
PMID: 38508337
No abstract available.
3.
Brown A, Laidlaw T, Buchheit K, Bensko J, Corcoran R, Bailey L
J Allergy Clin Immunol Pract
. 2024 Mar;
12(6):1647-1648.
PMID: 38484871
No abstract available.
4.
Bailey L, Brown A, Corcoran R, Bensko J, Buchheit K, Laidlaw T
J Allergy Clin Immunol Pract
. 2024 Feb;
12(6):1644-1646.e2.
PMID: 38423289
No abstract available.
5.
Lundberg M, Maurer R, Tchekmedyian R, Mullur J, Bensko J, Buchheit K, et al.
Allergy Asthma Proc
. 2023 Dec;
45(1):5-13.
PMID: 38151738
Olfactory dysfunction (OD) and smell loss affects aspects of patients' everyday life and lowers their quality of life. OD questionnaires are considered one of the core-outcome measures in chronic rhinosinusitis,...
6.
Buchheit K, Hacker J, Maurer R, McGill A, Ryan T, Bensko J, et al.
Clin Exp Allergy
. 2023 May;
53(9):974-977.
PMID: 37246613
No abstract available.
7.
Bensko J, McGill A, Palumbo M, Cahill K, Laidlaw T
J Allergy Clin Immunol Pract
. 2022 Jun;
10(9):2466-2468.
PMID: 35643277
No abstract available.
8.
Tchekmedyian R, Lundberg M, Buchheit K, Maurer R, Gakpo D, Mullur J, et al.
Clin Exp Allergy
. 2022 May;
52(12):1414-1421.
PMID: 35506180
Background: The impact of anosmia on quality-of-life (QoL) for patients with aspirin-exacerbated respiratory disease (AERD) is poorly understood. We aimed to investigate how the severity of smell loss and olfactory...
9.
Buchheit K, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko J, et al.
J Allergy Clin Immunol
. 2022 Apr;
150(2):415-424.
PMID: 35460728
Background: Dupilumab, a mAb targeting IL-4Rα, improves upper and lower airway symptoms in patients with aspirin-exacerbated respiratory disease (AERD), but the mechanisms leading to clinical improvement are not fully elucidated....
10.
Mullur J, Steger C, Gakpo D, Bensko J, Maurer R, Laidlaw T, et al.
Ann Allergy Asthma Immunol
. 2022 Feb;
128(5):575-582.
PMID: 35131410
Background: Patterns of medication use and efficacy in aspirin-exacerbated respiratory disease (AERD) have not been well characterized, especially since the advent of respiratory biologics. Aspirin therapy after desensitization (ATAD) is...